,title,source,link,date
0,Selpercatinib Elicits Notable PFS Benefit in RET+ Medullary Thyroid ...,Cancer Network,news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvc2VscGVyY2F0aW5pYi1lbGljaXRzLW5vdGFibGUtcGZzLWJlbmVmaXQtaW4tcmV0LW1lZHVsbGFyeS10aHlyb2lkLWNhbmNlctIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
19,ASCO Reading Room | Immunotherapy for ROS1-Rearranged ...,Medpage Today,news.google.com/articles/CBMiNGh0dHBzOi8vd3d3Lm1lZHBhZ2V0b2RheS5jb20vYXNjby9sdW5nLWNhbmNlci8xMDYwNDDSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
79,Association of ERCC family mutations with prognosis and immune ...,Nature.com,news.google.com/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvczQxNTk4LTAyMy00MDE4NS030gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
73,Polatuzumab Vedotin Demonstrates Tolerable Safety Profile in ...,Cancer Network,news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvcG9sYXR1enVtYWItdmVkb3Rpbi1kZW1vbnN0cmF0ZXMtdG9sZXJhYmxlLXNhZmV0eS1wcm9maWxlLWluLWFnZ3Jlc3NpdmUtbGJjbHPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
69,Will Jakaviâ€™s added evidence for PV cure lead to reimbursement in Korea?,KBR,news.google.com/articles/CBMiPWh0dHBzOi8vd3d3LmtvcmVhYmlvbWVkLmNvbS9uZXdzL2FydGljbGVWaWV3Lmh0bWw_aWR4bm89MjE5MTbSAUBodHRwczovL3d3dy5rb3JlYWJpb21lZC5jb20vbmV3cy9hcnRpY2xlVmlld0FtcC5odG1sP2lkeG5vPTIxOTE2?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
57,Tool helps improve accuracy of focal therapy for prostate cancer,Urology Times,news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LnVyb2xvZ3l0aW1lcy5jb20vdmlldy90b29sLWhlbHBzLWltcHJvdmUtYWNjdXJhY3ktb2YtZm9jYWwtdGhlcmFweS1mb3ItcHJvc3RhdGUtY2FuY2Vy0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
82,"Three years of Platypus, and five suggestions to improve Phase 2",Linklaters,news.google.com/articles/CBMiuwFodHRwczovL3d3dy5saW5rbGF0ZXJzLmNvbS9lbi9pbnNpZ2h0cy9wdWJsaWNhdGlvbnMvcGxhdHlwdXMvcGxhdHlwdXMtdWstbWVyZ2VyLWNvbnRyb2wtYW5hbHlzaXMvZWlnaHRlZW50aC1wbGF0eXB1cy1wb3N0LS0tdGhyZWUteWVhcnMtb2YtcGxhdHlwdXMtYW5kLWZpdmUtc3VnZ2VzdGlvbnMtdG8taW1wcm92ZS1waGFzZS0y0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
44,Dara-KRd Quadruplet Makes Waves in Newly Diagnosed Multiple ...,OncLive,news.google.com/articles/CBMiYGh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvZGFyYS1rcmQtcXVhZHJ1cGxldC1tYWtlcy13YXZlcy1pbi1uZXdseS1kaWFnbm9zZWQtbXVsdGlwbGUtbXllbG9tYdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
40,FDA Accepts sBLA for Amivantamab/Chemo in EGFR Exon 20+ ...,Cancer Network,news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvZmRhLWFjY2VwdHMtc2JsYS1mb3ItYW1pdmFudGFtYWItY2hlbW8taW4tZWdmci1leG9uLTIwLW5zY2xj0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
36,Charina Toste Discusses the Educational Obstacles Patients With ...,www.oncnursingnews.com/,news.google.com/articles/CBMibWh0dHBzOi8vd3d3Lm9uY251cnNpbmduZXdzLmNvbS92aWV3L2NoYXJpbmEtdG9zdGUtZGlzY3Vzc2VzLXRoZS1lZHVjYXRpb25hbC1vYnN0YWNsZXMtcGF0aWVudHMtd2l0aC1tcG5zLWZhY2XSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
